Treatment of childhood spasticity of cerebral origin with intrathecal baclofen: a series of 52 cases.

Continuous intrathecal baclofen infusion (CIBI) for spasticity of spinal and cerebral origin has been practised for over two decades. More recently, it has been used for severe spasticity of cerebral origin in children. Intrathecal baclofen (ITB) appears most beneficial in severe spastic tetrapareti...

Full description

Bibliographic Details
Main Authors: Fitzgerald, J, Tsegaye, M, Vloeberghs, M
Format: Journal article
Language:English
Published: 2004
_version_ 1797104711014285312
author Fitzgerald, J
Tsegaye, M
Vloeberghs, M
author_facet Fitzgerald, J
Tsegaye, M
Vloeberghs, M
author_sort Fitzgerald, J
collection OXFORD
description Continuous intrathecal baclofen infusion (CIBI) for spasticity of spinal and cerebral origin has been practised for over two decades. More recently, it has been used for severe spasticity of cerebral origin in children. Intrathecal baclofen (ITB) appears most beneficial in severe spastic tetraparetics or tetraplegics, but the evaluation of the outcome of ITB and the benefit of the treatment are largely subjective. The evidence base for this treatment has been questioned, in particular for ambulant children, mainly because of the lack of objective outcome measures. Fifty-two spastic tetraparetic children have been treated by this method in Nottingham, from 1998 to 2003. This represents a large homogeneous series of CIBI in children with severe spasticity of cerebral origin. We carried out a prospective audit of our experience, morbidity and observations during that period. We identified that the lack of a suitable scoring system for the evaluation of effectiveness and benefit is a drawback. As a result of these observations a multicentre randomized controlled trial on ITB in tetraplegia-paresis and ambulant children is advocated.
first_indexed 2024-03-07T06:37:25Z
format Journal article
id oxford-uuid:f820570b-dac4-4b44-8bec-e14d14ce77e9
institution University of Oxford
language English
last_indexed 2024-03-07T06:37:25Z
publishDate 2004
record_format dspace
spelling oxford-uuid:f820570b-dac4-4b44-8bec-e14d14ce77e92022-03-27T12:47:58ZTreatment of childhood spasticity of cerebral origin with intrathecal baclofen: a series of 52 cases.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f820570b-dac4-4b44-8bec-e14d14ce77e9EnglishSymplectic Elements at Oxford2004Fitzgerald, JTsegaye, MVloeberghs, MContinuous intrathecal baclofen infusion (CIBI) for spasticity of spinal and cerebral origin has been practised for over two decades. More recently, it has been used for severe spasticity of cerebral origin in children. Intrathecal baclofen (ITB) appears most beneficial in severe spastic tetraparetics or tetraplegics, but the evaluation of the outcome of ITB and the benefit of the treatment are largely subjective. The evidence base for this treatment has been questioned, in particular for ambulant children, mainly because of the lack of objective outcome measures. Fifty-two spastic tetraparetic children have been treated by this method in Nottingham, from 1998 to 2003. This represents a large homogeneous series of CIBI in children with severe spasticity of cerebral origin. We carried out a prospective audit of our experience, morbidity and observations during that period. We identified that the lack of a suitable scoring system for the evaluation of effectiveness and benefit is a drawback. As a result of these observations a multicentre randomized controlled trial on ITB in tetraplegia-paresis and ambulant children is advocated.
spellingShingle Fitzgerald, J
Tsegaye, M
Vloeberghs, M
Treatment of childhood spasticity of cerebral origin with intrathecal baclofen: a series of 52 cases.
title Treatment of childhood spasticity of cerebral origin with intrathecal baclofen: a series of 52 cases.
title_full Treatment of childhood spasticity of cerebral origin with intrathecal baclofen: a series of 52 cases.
title_fullStr Treatment of childhood spasticity of cerebral origin with intrathecal baclofen: a series of 52 cases.
title_full_unstemmed Treatment of childhood spasticity of cerebral origin with intrathecal baclofen: a series of 52 cases.
title_short Treatment of childhood spasticity of cerebral origin with intrathecal baclofen: a series of 52 cases.
title_sort treatment of childhood spasticity of cerebral origin with intrathecal baclofen a series of 52 cases
work_keys_str_mv AT fitzgeraldj treatmentofchildhoodspasticityofcerebraloriginwithintrathecalbaclofenaseriesof52cases
AT tsegayem treatmentofchildhoodspasticityofcerebraloriginwithintrathecalbaclofenaseriesof52cases
AT vloeberghsm treatmentofchildhoodspasticityofcerebraloriginwithintrathecalbaclofenaseriesof52cases